No effect of blood transfusions or HLA matching on renal graft success rate in recipients treated with cyclosporine-prednisolone or cyclosporine-azathioprine-prednisolone: the Scandinavian experience
Brynger, H.; Persson, H.; Flatmark, A.; Albrechtsen, D.; Frödin, L.; Tufvesson, G.; Gäbel, H.; Weibull, H.; Möller, E.; Lundgren, G.
Transplantation Proceedings 20(3 Suppl 3: 261-263
1988
ISSN/ISBN: 0041-1345 PMID: 3291253 Document Number: 312482
Document emailed within 1 workday
Related Documents
Francis, D.M.; Walker, R.G.; Jones, C.; Powell, H. 1994: Cessation of steroids in pediatric renal transplant recipients treated with cyclosporine, azathioprine, and prednisolone Transplantation Proceedings 26(1): 99-101Reissi, D.; Bardideh, A.; Samadzadeh, B.; Razi, A. 1995: Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation Transplantation Proceedings 27(5): 2685-2686
Oka, K.; Shimodaira, H.; Hirano, T.; Sakurai, E.; Tamaki, T.; Kozaki, M. 1993: Comparison of adrenal functions in kidney transplant recipients with different long-term immunosuppressive treatments--prednisolone and azathioprine versus prednisolone and cyclosporine Transplantation 56(3): 603-609
O'Connell, P.; d'Apice, A.; Walker, R.; Francis, D.; Kincaid-Smith, P. 1988: Cessation of steroids in renal allograft recipients on combined cyclosporine A, azathioprine, and prednisolone Transplantation Proceedings 20(1): 11-13
Lundgren, G.; Albrechtsen, D.; Brynger, H.; Flatmark, A.; Frödin, L.; Gäbel, H.; Lindholm, A.; Maurer, W.; Möller, E.; Persson, H. 1987: Role of HLA matching and pretransplant blood transfusions in cyclosporine-treated recipients of cadaveric renal allografts: 2- to 3-year results Transplantation Proceedings 19(5): 3614-3618
Tegzess, A.M.; van Son, W.J.; de Maar, E.F.; Beelen, J.M.; Sluiter, W.J.; Huisman, R.M. 1989: Elective conversion from cyclosporine to azathioprine and prednisolone in patients after cadaveric renal transplantation: observations on graft survival and renal function Transplantation Proceedings 21(1 Part 2): 1635-1637
Kerman, R.H.; Van Buren, C.T.; Lewis, R.M.; Kahan, B.D. 1988: Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients Transplantation Proceedings 20(3 Suppl 3: 264-269
Lorber, M.I.; Flechner, S.M.; Van Buren, C.T.; Kerman, R.H.; Kahan, B.D. 1985: Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 282-285
Opelz, G.; Schwarz, V.; Engelmann, A.; Back, D.; Wilk, M.; Keppel, E. 1991: Long-term impact of HLA matching on kidney graft survival in cyclosporine-treated recipients Transplantation Proceedings 23(1 Part 1): 373-375
Lai, M.K.; Huang, C.C.; Chu, S.H.; Chuang, C.K.; Fong, M.T. 1989: Renal transplantation in hepatitis B carriers: comparison of azathioprine- and cyclosporine-treated recipients Clinical Transplants 1989: 281-286
Sheil, A.G.; Disney, A.P.; Mathew, T.H.; Amiss, N.; Excell, L. 1991: Cancer development in cadaveric donor renal allograft recipients treated with azathioprine (AZA) or cyclosporine (CyA) or AZA/CyA Transplantation Proceedings 23(1 Part 2): 1111-1112
Zanker, B.; Barth, C.; Menges, A.V.; Lammerding, P.; Stachowski, J.; Baldamus, C.A. 1995: Expression of the multidrug resistance gene MDR-1 in peripheral blood mononuclear cells from cyclosporine-treated renal transplant recipients rejecting their graft Transplantation Proceedings 27(1): 925-926
Rogerson, M.E.; Neild, G.H.; Rudge, C.J.; Wood, S.M.; Cairns, H.S.; Mansell, M.A.; Thompson, F.D. 1988: Renal transplants maintained on low-dose cyclosporine and prednisolone Transplantation Proceedings 20(3 Suppl 3): 114-116
Carpenter, C.B.; Milford, E.L.; Kirkman, R.L.; Strom, T.B.; Lazarus, J.M.; Tilney, N.L. 1985: Stability of renal allograft recipients after conversion from cyclosporine to azathioprine Transplantation Proceedings 17(4 Suppl 1: 261-265
Kokado, Y.; Ishibashi, M.; Jiang, H.; Takahara, S.; Sonoda, T. 1989: A new triple-drug induction therapy with low dose cyclosporine, mizoribine and prednisolone in renal transplantation Transplantation Proceedings 21(1 Pt 2): 1575-1578
Lloveras, J.J.; Durand, D.; Ader, J.L.; Tran Van, T.; Rostaing, L.; Cerene, A.; Fournial, G.; Suc, J.M. 1993: Evolution of glomerular filtration rate and renal plasma flow in cyclosporine-treated heart transplant recipients over a 1-year period Transplantation Proceedings 25(3): 2226
Vanrenterghem, Y.; Waer, M.; De Keyser, P.; Roels, L.; Michielsen, P. 1988: Controlled trial of the protective effect of dihydroergotoxine (Hydergine) on cyclosporine-associated nephrotoxicity in renal graft recipients Transplantation Proceedings 20(3 Suppl 3: 615-617
Marumo, F.; Okubo, M.; Yokota, K.; Uchida, H.; Kumano, K.; Endo, T.; Watanabe, K.; Kashiwagi, N. 1988: A clinical study of renal transplant patients receiving triple-drug therapy--cyclosporine A, mizoribine, and prednisolone Transplantation Proceedings 20(1 Suppl 1: 406-409
Sandrini, S.; Maiorca, R.; Scolari, F.; Cancarini, G.; Setti, G.; Gaggia, P.; Cristinelli, L.; Zubani, R.; Bonardelli, S.; Maffeis, R.; Portolani, N.; Nodari, F.; Giulini, S.M. 2000: A prospective randomized trial on azathioprine addition to cyclosporine versus cyclosporine monotherapy at steroid withdrawal, 6 months after renal transplantation Transplantation 69(9): 1861-1867
Allegra, A.; Corica, F.; Ientile, R.; Corsonello, A.; Sparacino, V.; Accettola, F.; Caputo, F.; Macaione, S.; Buemi, M. 1998: Plasma (total and ionized), erythrocyte and platelet magnesium levels in renal transplant recipients during cyclosporine and/or azathioprine treatment Magnesium Research 11(1): 11-18